MYD88 mutations in clonal hematopoiesis promote inflammation and hematopoietic stem cell expansion
Authors:
Preprint
Abstract
Clonal hematopoiesis of indeterminate potential (CHIP) is characterized by expansion of mutant hematopoietic stem and progenitor cells (HSPCs) and an increased risk of chronic diseases and cancers. While mutations in DNMT3A , TET2 , and ASXL1 are common in CHIP, the contribution of less frequent gene mutations is not well understood. Here, we report MYD88 mutations, including lymphoma-associated and novel variants in blood cells of the general population and newly diagnosed solid cancer patients. MYD88 CHIP mutations in HSPCs activate NF-κB, indicating a gain-of-function activity. Modeling MYD88 CHIP in mice, Myd88 L252P (equivalent of human L265P) expression resulted in a competitive fitness advantage of HSPCs. Myd88 L252P HSPCs exhibit a myeloid cell bias and inflammation, leading to hematologic disease. Single-cell RNA sequencing indicated that Myd88 L252P expands distinct hematopoietic and immune cell clusters and activates immune-related pathways in HSPCs. An IRAK1/4 inhibitor suppressed MYD88-dependent NF-κB activation and reversed Myd88 L252P cell expansion. Overall, MYD88 mutations contribute to CHIP by inducing innate immune pathways in HSPCs and inflammatory disease.Keywords
This publication has 70 references indexed in Scilit:
- Clonal hematopoiesis driven by mutated DNMT3A promotes inflammatory bone lossCell, 2024
- Clonal hematopoiesis of indeterminate potential and clonal cytopenias of undetermined significance: 2023 update on clinical associations and management recommendationsAmerican Journal of Hematology, 2023
- Temporal multimodal single-cell profiling of native hematopoiesis illuminates altered differentiation trajectories with ageCell Reports, 2023
- TET2-Driven Clonal Hematopoiesis and Response to CanakinumabJAMA Cardiology, 2022
- Clonal hematopoiesis as a model for premalignant changes during agingExperimental Hematology, 2020
- Non-catalytic Roles of Tet2 Are Essential to Regulate Hematopoietic Stem and Progenitor Cell HomeostasisCell Reports, 2019
- TRAF6 Mediates Basal Activation of NF-κB Necessary for Hematopoietic Stem Cell HomeostasisCell Reports, 2018
- Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult LifeThe American Journal of Human Genetics, 2017
- Targeting IRAK1 as a Therapeutic Approach for Myelodysplastic SyndromeCancer Cell, 2013
- Tet2 Loss Leads to Increased Hematopoietic Stem Cell Self-Renewal and Myeloid TransformationCancer Cell, 2011